HKEX Stock Code: 01093English|繁體|简体

Highlight - 2025 Annual Results

Revenue
RMB26,006M, -10.4%
Reported profit attributable to shareholders of the Company
RMB3,882M, -10.3%
Underlying profit attributable to shareholders of the Company
RMB3,534M, -24.5%
Basic earnings per share (based on reported profit)
RMB33.98 cents, -7.8%

Key Products

Finished drugs
Bulk drugs
© Copyright 2026 CSPC Pharmaceutical Group Limited. All Rights Reserved.